GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Other Assets for Insurance Companies

GH Research (FRA:1KA) Other Assets for Insurance Companies


View and export this data going back to 2021. Start your Free Trial

What is GH Research Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


GH Research (FRA:1KA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Other Assets for Insurance Companies
Traded in Other Exchanges
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.